BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32574650)

  • 1. Cannabidiol anticonvulsant effect is mediated by the PI3Kγ pathway.
    Lima IVA; Bellozi PMQ; Batista EM; Vilela LR; Brandão IL; Ribeiro FM; Moraes MFD; Moreira FA; de Oliveira ACP
    Neuropharmacology; 2020 Oct; 176():108156. PubMed ID: 32574650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PI3Kγ deficiency enhances seizures severity and associated outcomes in a mouse model of convulsions induced by intrahippocampal injection of pilocarpine.
    Lima IV; Campos AC; Miranda AS; Vieira ÉL; Amaral-Martins F; Vago JP; Santos RP; Sousa LP; Vieira LB; Teixeira MM; Fiebich BL; Moraes MF; Teixeira AL; de Oliveira AC
    Exp Neurol; 2015 May; 267():123-34. PubMed ID: 25749189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor-independent mechanism.
    Hill TD; Cascio MG; Romano B; Duncan M; Pertwee RG; Williams CM; Whalley BJ; Hill AJ
    Br J Pharmacol; 2013 Oct; 170(3):679-92. PubMed ID: 23902406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabidiol effect in pentylenetetrazole-induced seizures depends on PI3K.
    de Assis Lima IV; Pinto HPP; Bellozi PMQ; da Silva MCM; Vilela LR; Moreira FA; Moraes MFD; de Oliveira ACP
    Pharmacol Rep; 2022 Oct; 74(5):1099-1106. PubMed ID: 36112318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabidiol Anticonvulsant Effects Against Lithium-Pilocarpine-Induced Status Epilepticus in Male Rats Are Mediated by Neuroinflammation Modulation and Cannabinoids 1 (CB1), But Not CB2 and GABA
    Masoumi M; Manavi MA; Mohammad Jafari R; Mirzaei A; Hedayatyanfard K; Beigmohammadi MT; Dehpour AR
    Cannabis Cannabinoid Res; 2024 Jun; 9(3):797-808. PubMed ID: 37976207
    [No Abstract]   [Full Text] [Related]  

  • 6. Anticonvulsant effect of cannabidiol in the pentylenetetrazole model: Pharmacological mechanisms, electroencephalographic profile, and brain cytokine levels.
    Vilela LR; Lima IV; Kunsch ÉB; Pinto HPP; de Miranda AS; Vieira ÉLM; de Oliveira ACP; Moraes MFD; Teixeira AL; Moreira FA
    Epilepsy Behav; 2017 Oct; 75():29-35. PubMed ID: 28821005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo.
    Jones NA; Hill AJ; Smith I; Bevan SA; Williams CM; Whalley BJ; Stephens GJ
    J Pharmacol Exp Ther; 2010 Feb; 332(2):569-77. PubMed ID: 19906779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Utility of Cannabidiol in the Treatment of Refractory Epilepsy.
    Reddy DS
    Clin Pharmacol Ther; 2017 Feb; 101(2):182-184. PubMed ID: 27506704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticonvulsant and Neuroprotective Effects of Cannabidiol During the Juvenile Period.
    Friedman LK; Wongvravit JP
    J Neuropathol Exp Neurol; 2018 Oct; 77(10):904-919. PubMed ID: 30169677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabidiol, a Cannabis sativa constituent, inhibits cocaine-induced seizures in mice: Possible role of the mTOR pathway and reduction in glutamate release.
    Gobira PH; Vilela LR; Gonçalves BD; Santos RP; de Oliveira AC; Vieira LB; Aguiar DC; Crippa JA; Moreira FA
    Neurotoxicology; 2015 Sep; 50():116-21. PubMed ID: 26283212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabidiol Post-Treatment Alleviates Rat Epileptic-Related Behaviors and Activates Hippocampal Cell Autophagy Pathway Along with Antioxidant Defense in Chronic Phase of Pilocarpine-Induced Seizure.
    Hosseinzadeh M; Nikseresht S; Khodagholi F; Naderi N; Maghsoudi N
    J Mol Neurosci; 2016 Apr; 58(4):432-40. PubMed ID: 26738731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voltage-gated sodium (NaV) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se.
    Hill AJ; Jones NA; Smith I; Hill CL; Williams CM; Stephens GJ; Whalley BJ
    Neurosci Lett; 2014 Apr; 566():269-74. PubMed ID: 24642454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anticonvulsant effects of cannabidiol in experimental models of epileptic seizures: From behavior and mechanisms to clinical insights.
    Lazarini-Lopes W; Do Val-da Silva RA; da Silva-Júnior RMP; Leite JP; Garcia-Cairasco N
    Neurosci Biobehav Rev; 2020 Apr; 111():166-182. PubMed ID: 31954723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabidiol induces systemic analgesia through activation of the PI3Kγ/nNOS/NO/KATP signaling pathway in neuropathic mice. A KATP channel S-nitrosylation-dependent mechanism.
    de Almeida DL; Mendes Ferreira RC; Fonseca FC; Dias Machado DP; Aguiar DD; Guimaraes FS; Duarte IDG; Romero TRL
    Nitric Oxide; 2024 May; 146():1-9. PubMed ID: 38428514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome.
    Kaplan JS; Stella N; Catterall WA; Westenbroek RE
    Proc Natl Acad Sci U S A; 2017 Oct; 114(42):11229-11234. PubMed ID: 28973916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabidiol regulates CB1-pSTAT3 signaling for neurite outgrowth, prolongs lifespan, and improves health span in Caenorhabditis elegans of Aβ pathology models.
    Wang Z; Zheng P; Xie Y; Chen X; Solowij N; Green K; Chew YL; Huang XF
    FASEB J; 2021 May; 35(5):e21537. PubMed ID: 33817834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models.
    Patra PH; Barker-Haliski M; White HS; Whalley BJ; Glyn S; Sandhu H; Jones N; Bazelot M; Williams CM; McNeish AJ
    Epilepsia; 2019 Feb; 60(2):303-314. PubMed ID: 30588604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures.
    Jones NA; Glyn SE; Akiyama S; Hill TD; Hill AJ; Weston SE; Burnett MD; Yamasaki Y; Stephens GJ; Whalley BJ; Williams CM
    Seizure; 2012 Jun; 21(5):344-52. PubMed ID: 22520455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Pharmacological Basis of Cannabis Therapy for Epilepsy.
    Reddy DS; Golub VM
    J Pharmacol Exp Ther; 2016 Apr; 357(1):45-55. PubMed ID: 26787773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis for the Treatment of Epilepsy: an Update.
    Gaston TE; Szaflarski JP
    Curr Neurol Neurosci Rep; 2018 Sep; 18(11):73. PubMed ID: 30194563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.